Literature DB >> 12148298

[Keratoprostheses. Clinical aspects].

K Hille1.   

Abstract

In patients with dry eye, like pemphigoid, Fuchs-Stevens-Johnson syndrome and xerophthalmia, in eyes with severe vascularisation of the cornea due to severe burns, in a leucoma adherens or following recurrent transplant rejections as well as in cloudy corneas of silicone-filled eyes, restoration of visual acuity can often only be achieved by a keratoprosthesis. In the case of an intact posterior segment and retinal function a normal visual acuity can be anticipated but mostly with a restricted visual field. Complications vary from glaucoma, retroprosthetic membranes, necrosis of the recipient tissue at the rim of the prosthesis, endophthalmitis, loosening and loss of the prosthesis even to the loss of visual acuity. With some types of prostheses the visual acuity will be reduced again within a short time, but in osteo-odonto-keratoprostheses, using the root of a patients tooth as haptic material for the optical cylinder, good long-term results even for several decades are possible. In patients without suitable teeth, prostheses with biointegrable materials such as Pintucci keratoprostheses can be used. A basic rule is that a secondary glaucoma, which in this patient group frequently develops even preoperatively, must be treated adequately.

Entities:  

Mesh:

Year:  2002        PMID: 12148298     DOI: 10.1007/s00347-002-0659-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

1.  Medium term results in keratoprostheses with biocompatible and biological haptic.

Authors:  K Hille; A Hille; K W Ruprecht
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-19       Impact factor: 3.117

Review 2.  [Current treatment options with artificial corneas: Boston Kpro, Osteo-odontokeratoprosthesis, Miro Cornea® and KeraKlear®].

Authors:  N Schrage; K Hille; C Cursiefen
Journal:  Ophthalmologe       Date:  2014-11       Impact factor: 1.059

3.  Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.

Authors:  J L Alió; M E Mulet; H Haroun; J Merayo; J M Ruiz Moreno
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

4.  [Results with the Boston keratoprosthesis].

Authors:  B Koller; T Neuhann; I Neuhann
Journal:  Ophthalmologe       Date:  2012-05       Impact factor: 1.059

5.  Vision Rehabilitation with a Native Pintucci-type Keratoprosthesis.

Authors:  Saeed Rahmani; Abbas Bagheri; Farid Karimian; Mohammad Ali Javadi; Siamak Delfazayebaher
Journal:  J Ophthalmic Vis Res       Date:  2019 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.